Interest of glycolipids in drug delivery: From physicochemical properties to drug targeting

Expert Opinion on Drug Delivery

Volumn 7, Issue 9, 2010, Pages 1031-1048

  Faivre, Vincent ^a   Rosilio, Véronique ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Adhesions; Biosurfactants; Cubosomes; Drug targeting; Gelators; Hexosomes; Lectins; Liposomes; Surfactants

Indexed keywords

BETA SISTOSTEROL GLUCOSIDE; BIOSURFACTANT; CARBOHYDRATE BINDING PROTEIN; CHOLESTEROL; CUBOSOME; DIRHAMNOLIPID; GALACTOSYLCERAMIDE; GALACTOSYLDIACYLGLYCEROL; GLYCOLIPID; GLYCOPEPTIDE; GLYCOPROTEIN; GLYCOSPHINGOLIPID; HEXOSOME; LECTIN; LIPID A; LIPOPOLYSACCHARIDE; MANNOSYLERYTHRITOL LIPID; MONORHAMNOLIPID; NANOPARTICLE; NIOSOME; OCTADECYLAMINE; PEPTIDOGLYCAN; PROPOFOL; PROTEOGLYCAN; RHAMNOLIPID; SOPHOROLIPID; SORBITAN ESTER; SUCROSE ESTER DERIVATIVE; TREHALOSE LIPID; UNCLASSIFIED DRUG; WATER OIL CREAM;

CELL ADHESION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TARGETING; GEL; HUMAN; HYDROPHILICITY; LIPOPHILICITY; MICROEMULSION; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SIGNAL TRANSDUCTION;

EID: 77955881505     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2010.511172     Document Type: Review

References (136)

1. Zhang T, Marchant RE. Novel polysaccharide surfactants: the effect of hydrophobic and hydrophilic chain length on surface active properties. J Colloid Interface Sci 1996;177:419-426
2. Kampulainen AJ, Persson CM, Eriksson JC. n-Decyl-glucopyranoside and n-decyl-maltopyranoside Gibbs monolayers. Phase changes in the dilute liquid-expanded range. Langmuir 2004;20:10534-10541
3. Milkereit G, Garamus VM, Gerber S, Willumeit R. Self-assembly properties of alkyloxyethyl-glycosides with different types of carbohydrate headgroups. Langmuir 2007;23:11488-11495
4. Falkoner RA, Toth I. Design, synthesis and biological evaluation of novel lipoamino acid-based glycolipids for oral drug delivery. Bioorg Med Chem 2007;15:7012-7020
5. Maget-Dana R, Roche AC, Monsigny M. Interaction between vesicles containing gangliosides and lectins. Limulin and wheat germ agglutinin. FEBS Lett 1977;79:305-309
6. Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998;34:191-219
7. Bies C, Lehr C-M, Woodley JF. Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev 2004;56:425-435
8. Bridges JF, Woodley JF, Duncan R, Kopecek J. Soluble N-(2-hydroxypropyl) methacrylamide copolymers as a potential oral, controlled-release, drug delivery system. I. Bioadhesion to the rat intestine in vitro. Int J Pharm 1988;44:213-223
9. Rodrigues JS, Santos-Magalhaes NS, Coelho LCBB, et al. Novel core (polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. J Control Release 2003;92:103-112
10. Lehr MC, Gabor F. Lectins and glycoconjugates in drug delivery and targeting. Adv Drug Deliv Rev 2004;56:419-420
11. Gabor F, Bogner E, Weissenboeck A, Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev 2004;56:459-480
12. Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev 2004;56:491-509
13. Berthelot L, Rosilio V, Costa ML, et al. Behavior of amphiphilic neoglycolipids at the air/solution interface. Interaction with a specific lectin. Colloids Surf B Biointerfaces 1998;11:239-248
14. Faivre V, Costa ML, Boullanger P, et al. Specific interactions of lectins with liposomes and monolayers bearing neoglycolipids. Chem Phys Lipids 2003;125:147-159
15. Rico-Lattes I, Blanzat M, Franceschi-Messant S, et al. Catanionic sugar derived surfactants, polymers and dendrimers: from molecules to targeted self-organized systems. CR Chimie 2005;8(5):807-814
16. Chester MA. Nomenclature of glycolipids. Pure Appl Chem 1997;69:2475-2487
17. Warnecke D, Heinz E. Glycolipid headgroups replacement: a new approach for the analysis of specific functions of glycolipids in vivo. Eur J Cell Biol 2010;89:53-61
18. Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids. J Lipid Res 2005;46:839-861
19. Wennekes T, van den Berg RJBHN, Boot RG, et al. Glycosphingolipids- Nature, function, and pharmacological modulation. Angew Chem Int Ed 2009;48:8848-8869
20. Ohmi Y, Tajima O, Ohkawa Y, et al. Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. PNAS 2009;106:22405-22410
21. Fahy E, Subramaniam S, Murphy RC, et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009;50:S9-14
22. Dynarowicz-Latka P, Rosilio V, Boullanger P, et al. The influence of a neoglycolipid and of its PEO-lipid moiety on the organization of hospholipids monolayers. Langmuir 2005;21:11941-11948
23. Faivre V, Rosilio V, Martins-Almeida L, et al. Fucosyled neoglycolipids: synthesis and interaction with a phospholipid. Chem Phys Lipids 2001;109:91-101
24. Ewers H, Romer W, Smith AE, et al. GM1 structure determines SV40-induced membrane invagination and infection. Nat Cell Biol 2010;12:11-18
25. Jones MR. Lipids in photosynthetic reaction centres: structural roles and functional holes. Prog Lipid Res 2007;46:56-87
26. Gelhausen M, Besson F, Chierici S, et al. Lectin recognition of liposomes containing neoglycolipids. Influence of their lipidic anchor and spacer length. Colloids Surf B Biointerfaces 1998;10:395-404
27. Bush CA, Martin-Pastor M, Imberty A. Structure and conformation of complex carbohydrates of glycoproteins, glycolipids, and bacteril polysaccharides. Annu Rev Biophys Biomol Struct 1999;28:269-293
28. Lafont D, Bouchu MN, Girard-Egros A, Boullanger P. Syntheses and interfacial behaviour of neoglycolipid analogues of glycosyl ceramides. Carbohydrate Res 2001;336:181-194
29. Lingwood CA, Binnington B, Manis A, Branch DR. Globotriaosyl ceramide receptor function - Where membrane structure and pathology intersect. FEBS Lett 2010;584:1879-1886
30. Stromberg N, Ryd N, Lindberg AA, Karlsson KA. Studies on the binding of bacteria to glycolipids. Two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide. FEBS Lett 1988;232:193-198
31. Yahi N, Aulas A, Fantini J. How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40). PLoS ONE 2010;5:e9079
32. Wiels J, Holmes EH, Cochran N, et al. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. J Biol Chem 1984;259:14783-14787
33. Lichtenthaler FW. The key sugars of biomass: availability, present non-food uses and potential future development lines. Weinheim: Wiley-VCH, Verlag GmbH and Co; 2006
34. Hill K, Rhode O. Sugar-based surfactants for consumer products and technical applications. Lipid Fett 1999;101:25-33
35. Von Rybinski W, Hill K. Alkyl polyglycosides-properties and applications of a new class of surfactants. Angew Chem Int Ed 1998;37:1328-1345
36. Eastoe J, Rogueda P, Howe AM, Pitt AR. Properties of new glucamide surfactants. Langmuir 1996;12:2701-2705
37. Polat T, Linhardt R. Syntheses and applications of sucrose-based esters. J Surfactants Detergents 2001;4:415-421
38. Queneau Y, Chambert S, Besset C, Cheaib R. Recent progress in the synthesis of carbohydrate-based amphiphilic materials: the examples of sucrose and isomaltulose. Carbohydr Res 2008;343:1999-2009
39. Jonsson B, Lindman B, Holmberg K, et al. Surfactants and polymers in aqueous solution. Chichester: Wiley and Sons Ltd; 1998
40. Ruiz CC. Sugar-based surfactants: fundamentals and applications. CRC Press, Taylor and Francis Group, Boca Raton; 2008
41. Lanigan RS, Yamarik TA, Andersen FA. Final report on the safety assessment of sorbitan caprylate, sorbitan cocoate, sorbitan diisostearate, sorbitan dioleate, sorbitan distearate, sorbitan isostearate, sorbitan olivate, sorbitan sesquiisostearate, sorbitan sesquistearate, and sorbitan triisostearate. Int J Toxicol 2002;21:93-112
42. Fruijtier-Polloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology 2005;214:1-38
43. Date AA, Nagarsenker MS. Parenteral microemulsion: an overview. Int J Pharm 2008;355:19-30
44. Lee JM, Park KM, Lim SJ, et al. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction. Pharm Pharmacol 2002;54:43-49
45. Date AA, Nagarsenker MS. Design and evaluation of microemulsion for improved parenteral delivery of propofol. AAPS Pharm Sci Tech 2008;9:138-145
46. Graf A, Ablinger E, Peters S, et al. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm 2008;350:351-360
47. Pakpayat N, Nielloud F, Fortune R, et al. Formulation of ascorbic acid microemulsions with alkyl polyglycosides. Eur J Pharm Biopharm 2009;72:444-452
48. Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 1995;58:1-55
49. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33-70
50. Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 2008;357:189-198
51. Soderlind E, Wollbratt M, von Corswant C. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int J Pharm 2003;252:61-71
52. Ntawukulilyayo JD, Demuynck C, Remon JP. Microcrystalline cellulose-sucrose esters as tablet matrix forming agents. Int J Pharm 1995;121:205-210
53. Chansanroj K, Betz G. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction. Acta Biomater 2010;6:3092-3100
54. Szuts A, Budai-Szucs M, Eros I, et al. Study of gel-forming properties of sucrose esters for thermosensitive drug delivery systems. Int J Pharm 2010;383:132-137
55. Csoka G, Marton S, Zelko R, et al. Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 2007;65:233-237
56. Kitamoto D, Morita T, Fukuoka T, et al. Self-assembling properties of glycolipid biosurfactants and their potential applications. Curr Opin Colloid Interface Sci 2009;14:315-328
57. Lourith N, Kanlayavattanakul M. Natural surfactants used in cosmetics: glycolipids. Intern J Cosmet Sci 2009; 31:255-261
58. Arutchelvi J, Bhaduri S, Uppara P, Doble M. Mannosylerythritol lipids: a review. J Ind Microbiol Biotechnol 2008;35:1559-1570
59. Van Bogaert I, Saerens K, De Muynck C, et al. Microbial production and application of sophorolipids. Appl Microbiol Biotechnol 2007;76:23-34
60. Rahman PKSM, Gakpe E. Production, characterisation and applications of biosurfactants - review. Biotechnology 2008;7:360-370
61. Franzetti A, Gandolfi I, Bestetti G, et al. Production and applications of trehalose lipid biosurfactants. Eur J Lipid Sci Technol 2010;112:617-627
62. Rodrigues L, Banat IM, Teixeira J, Oliveira R. Biosurfactants: potential applications in medicine. J Antimicrob Chemother 2006;57:609-618
63. Cameotra SS, Makkar RS. Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 2004;7:262-266
64. Worakitkanchanakul W, Imura T, Fukuoka T, et al. Aqueous-phase behavior and vesicle formation of natural glycolipid biosurfactant, mannosylerythritol lipid-B. Colloids Surf B Biointerfaces 2008;65:106-112
65. Nguyen TTL, Edelen A, Neighbors B, Sabatini DA. Biocompatible lecithin-based microemulsions with rhamnolipid and sophorolipid biosurfactants: formulation and potential applications. J Colloid Interface Sci 2010;348:498-504
66. Imura T, Yanagishita H, Ohira J, et al. Thermodynamically stable vesicle formation from glycolipid biosurfactant sponge phase. Colloids Surf B Biointerfaces 2005;43:115-121
67. Inoh Y, Kitamoto D, Hirashima N, Nakanishi M. Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes. Biochem Biophys Res Commun 2001;289:57-61
68. Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release 2006;112:362-368
69. Inoh Y, Kitamoto D, Hirashima N, Nakanishi M. Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion. J Control Release 2004;94:423-431
70. Ueno Y, Inoh Y, Furuno T, et al. NBD-conjugated biosurfactant (MEL-A) shows a new pathway for transfection. J Control Release 2007;123:247-253
71. Muthusamy K, Gopalakrishnan S, Ravi TK, et al. Biosurfactants: properties, commercial production and application. Curr Sci 2008;94:736-747
72. Vill V, Hashim R. Carbohydrate liquid crystals: structure-property relationship of thermotropic and lyotropic glycolipids. Curr Opin Colloid Interface Sci 2002;7:395-409
73. Corti M, Cantu L, Brocca P, Del Favero E. Self-assembly in glycolipids. Curr Opin Colloid Interface Sci 2007;12:148-154
74. Howe J, Garidel P, Wulf M, et al. Structural polymorphism of hydrated monoacylated maltose glycolipids. Chem Phys Lipids 2008;155:31-37
75. Faivre V, Bardonnet P-L, Boullanger P, et al. Self-organization of synthetic cholesteryl oligoethyleneglycol glycosides in water. Langmuir 2009;25:9424-9431
76. Godeau G, Barthelemy P. Glycosyl-nucleoside lipids as low-molecular-weight gelators. Langmuir 2009;25:8447-8450
77. Nagarajan S, Das TM. A sugar-pyrene-based fluorescent gelator: nanotubular architecture and interaction with SWCNTs. New J Chem 2009;33:2391-2396
78. Cui J, Zheng J, Qiao W, Wan X. Solvent-tuned multiple self-assembly of a new sugar-appended gelator. J Colloid Interface Sci 2008;326:267-274
79. Cui J, Liu A, Guan Y, et al. Tuning the helicity of self-assembled structure of a sugar-based organogelator by the proper choice of cooling rate. Langmuir 2009;26:3615-3622
80. John G, Jung JH, Masuda M, Shimizu T. Unsaturation effect on gelation behavior of aryl glycolipids. Langmuir 2004;20:2060-2065
81. Gronwald O, Shinkai S. Sugar-integrated gelators of organic solvents. Chem A Eur J 2001; 7:4328-4334 (Pubitemid 33000549)
82. Bhattacharya S, Acharya SNG. Pronounced hydrogel formation by the self-assembled aggregates of N-alkyl disaccharide amphiphiles. Chem Mater 1999;11:3504-3511
83. Karinaga R, Jeong Y, Shinkai S, et al. Inclusion of DNA into organic gelator fibers made of amphipathic molecules and its controlled release. Langmuir 2005;21:9398-9401
84. Yaghmur A, Glatter O. Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci 2009;147-148:333-342
85. Boyd BJ, Whittaker DV, Khoo S-M, Davey G. Hexosomes formed from glycerate surfactants-Formulation as a colloidal carrier for irinotecan. Int J Pharm 2006;318:154-162
86. Abraham T, Hato M, Hirai M. Glycolipid based cubic nanoparticles: preparation and structural aspects. Colloids Surf B Biointerfaces 2004;35:107-118
87. Abraham T, Hato M, Hirai M. Polymer-dispersed bicontinuous cubic glycolipid nanoparticles. Biotechnol Prog 2005;21:255-262
88. Imura T, Hikosaka Y, Worakitkanchanakul W, et al. Aqueous-phase behavior of natural glycolipid biosurfactant mannosylerythritol lipid A: sponge, cubic, and lamellar Phases. Langmuir 2007;23:1659-1663
89. Drickamer K. C-type lectin-like domains. Curr Opin Struct Biol 1999;9:585-590
90. Hudgin RL, Pricer WE, Ashwell G, et al. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J Biol Chem 1974,249:5536-5543
91. Gupta A, Gupta RK, Gupta GS. Targeting cells for drug and gene delivery: emerging applications of mannans and mannan binding lectins. J Sci Ind Res 2009;68:465-483
92. Lu J, Teh C, Kishore U, Reid KBM. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 2002;1572:387-400
93. Rainer TH. L-selectin in health and disease. Resuscitation 2002;52:127-141
94. Ehrhardt C, Kneuer C, Bakowsky U. Selectins- an emerging target for drug delivery. Adv Drug Deliv Rev 2004;56:527-549
95. Ghazarian H, Idoni B, Oppenheimer SB. A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 2010; DOI:10.1016/j.acthis.2010.02.004
96. Nangia-Makker P, Conklin J, Hogan V, Raz A. Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med 2002;8:187-192
97. Francavilla C, Maddaluno L, Cavallaro U. The functional role of cell adhesion molecules in tumor angiogenesis. Semin Cancer Biol 2009;19:298-309
98. Witz IP. The involvement of selectins and their ligands in tumor-progression. Immunol Lett 2006;104:89-93
99. Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 2008;5:703-724
100. Barratt G, Tenu J-P, Yapo A, Petit JF. Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages. Biochim Biophys Acta Biomembranes 1986;862:153-164
101. Pathak A, Vyas SP, Gupta KC. Nano-vectors for efficient liver specific gene transfer. Int J Nanomed 2008;3:31-49
102. Kawakami S, Sato A, Nishikawa M, et al. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther Group 2000;7:292-299
103. Wijagkanalan W, Kawakami S, Takenaga M, et al. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 2008;125:121-130
104. Yeeprae W, Kawakami S, Yamashita F, et al. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release 2006;114:193-201
105. Kawakami S, Wong J, Sato A, et al. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 2000;1524:258-265
106. Kawakami S, Yamashita F, Nishikawa M, et al. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem Biophys Res Commun 1998;252:78-83
107. Nishikawa M, Kawakami S, Yamashita F, et al. Glycosylated cationic liposomes for carbohydrate receptor-mediated gene transfer. Methods in Enzymology. Academic Press, New York: 2003. p. 384-399
108. Chittima M, Shigeru K, Fumiyoshi Y, Mitsuru H. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci 2005;94:2266-2275
109. Lian J, Zhang S, Wang J, et al. Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate. J Drug Target 2008;16:250-256
110. Garg M, Asthana A, Agashe HB, et al. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics. J Pharm Pharmacol 2006;58:605-616
111. Garg M, Dutta T, Jain NK. Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes. Eur J Pharm Biopharm 2007;67:76-85
112. Garg M, Garg BR, Jain S, et al. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes. Eur J Pharm Sci 2008;33:271-281
113. Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target 2008;16:798-805
114. Mitra M, Mandal AK, Chatterjee TK, Das N. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis. J Drug Target 2005;13:285-293
115. Vodovozova EL, Moiseeva EV, Grechko GK, et al. Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLeX, in a mouse mammary adenocarcinoma model. Eur J Cancer 2000;36:942-949
116. Tsuruta W, Tsurushima H, Yamamoto T, et al. Application of liposomes incorporating doxorubicin with sialyl Lewis X to prevent stenosis after rat carotid artery injury. Biomaterials 2009;30:118-125
117. Zhu J, Xue J, Guo Z, et al. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Bioconjugate Chem 2007;18:1366-1369
118. Hirai M, Minematsu H, Hiramatsu Y, et al. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. Int J Pharm 2010;391:274-283
119. Zeisig R, Stahn R, Wenzel K, et al. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. Biochim Biophys Acta Biomembranes 2004;1660:31-40
120. Imberty A, Varrot A. Microbial recognition of human cell surface glycoconjugates. Curr Opin Struct Biol 2008;18:567-576
121. Pieters JR. Intervention with bacterial adhesion by multivalent carbohydrates. Med Res Rev 2007;27:796-816
122. Imberty A, Mitchell EP, Wimmerova M. Structural basis of high-affinity glycan recognition by bacterial and fungal lectins. Curr Opin Struct Biol 2005;15:525-534
123. An YH, Friedman RJ. Handbook of bacterial adhesion. Principles, methods, and applications. Humana Press Inc., Totowa; 2000
124. Ruiz-Bustos E, Ochoa JL, Wadstrom T, Ascencio F. Isolation and characterisation of putative adhesins from Helicobacter pylori with affinity for heparan sulphate proteoglycan. J Med Microbiol 2001;50:215-222
125. Skouloubris S, De Reuse H, Labigne A. Bacteriologie et pathogenicite d'Helicobacter pylori. Rev Prat 2000;50:1409-1413
126. Evans DJ Jr, Evans DG. Helicobacter pylori adhesins: review and perspectives. Helicobacter 2000;5:183-195
127. Mahdavi J, Sonden B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-578
128. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279:373-377
129. Petzold K, Olofsson A, Arnqvist A, et al. Helicobacter Pylori: how is adhesin BabA, a blood group antigen binding membrane protein, involved in bacterial adherence? Biophys J 2009;96:409a
130. Aspholm M, Kalia A, Ruhl S, et al. Helicobacter pylori adhesion to carbohydrates. Methods in Enzymology. Academic Press, New York: 2006. p. 293-339
131. Nimrichter L, Rodrigues ML, Rodrigues EG, Travassos LR. The multitude of targets for the immune system and drug therapy in the fungal cell wall. Microbes Infect 2005;7:789-798
132. Bardonnet PL, Faivre V, Pugh WJ, et al. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J Control Release 2006;111:1-18
133. Bardonnet PL, Faivre V, Pirot F, et al. Cholesteryl oligoethyleneglycol glycosides: fluidizing effect of their embedment into phospholipid bilayers. Biochem Biophys Res Commun 2005;329:1186-1192
134. Bardonnet P-L, Faivre V, Boullanger P, et al. Pre-formulation of liposomes against Helicobacter pylori: characterization and interaction with the bacteria. Eur J Pharm Biopharm 2008;69:908-922
135. Bardonnet P-L, Faivre V, Boullanger P, et al. Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions. Biochem Biophys Res Commun 2009;383:48-53 136.
136. Vyas SP, Sihorkar V, Jain S. Mannosylated liposomes for bio-film targeting. Int J Pharm 2007;330:6-13